Daniel J. Brennan
Independent DirectorMr. Daniel J. Brennan, also known as Dan, C.P.A. is an Independent Director of Vertex Pharmaceuticals Incorporated from October 20, 2026. Mr. Brennan serves as Independent Director at Waters Corporation since November 23, 2022. Mr. Brennan is an Independent Director of Madrigal Pharmaceuticals, Inc. from August 2025. He was Chief Financial Officer and Executive Vice President of Boston Scientific Corporation since January 1, 2014 until June 2025 and served as its Principal Accounting Officer. Mr. Brennan had been Independent Director of Nuance Communications, Inc. since September 12, 2018 until March 04, 2022. He served as Senior Vice President and Corporate Controller at Boston Scientific Corporation from February 2010 to 2013 and Assistant Corporate Controller in 2009 and also served as its Vice President of Investor Relations from November 2, 2006 to February 2010. He served as Vice President of International Finance of Boston Scientific Corp. He was Corporate Auditor at Standex, Inc. from 1988 to 1989. Mr. Brennan also served as Vice President of Cardiovascular Finance (Maple Grove, MN) as well as Director of Finance for two separate operating units in the Boston Scientific Endo-surgery Group. He served as Director of Boston Scientific Pty Ltd. until December 15, 2014. He holds a B.S. Degree in Finance and Investments and an M.B.A. from Babson College. Mr. Brennan is also a Certified Public Accountant.
Positions
- Company NameMadrigal Pharmaceuticals, Inc.Stock CodeMDGLPositionIndependent DirectorColleagues
- WJWilliam J. SiboldCEO, President & Director
- JCJulian Charles BakerIndependent Chairman of the Board
- RARebecca A. TaubFounder, Senior Scientific & Medical Advisor and Director
- MCMardi C. DierExecutive VP & CFO
- SKShannon KelleyExecutive VP, Chief Legal Officer & Corporate Secretary
- CHCarole HuntsmanExecutive VP & Chief Commercial Officer
- RSRichard Steven LevyIndependent Director
